Dupont Capital Management Corp Ultragenyx Pharmaceutical Inc. Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 30, 2021
SELL
$92.19 - $115.71 $223,652 - $280,712
-2,426 Closed
0 $0
Q1 2021

Apr 29, 2021
SELL
$106.9 - $167.73 $53,236 - $83,529
-498 Reduced 17.03%
2,426 $276,000
Q4 2020

Jan 28, 2021
SELL
$84.4 - $177.39 $18,483 - $38,848
-219 Reduced 6.97%
2,924 $405,000
Q3 2020

Oct 29, 2020
BUY
$72.98 - $90.0 $229,376 - $282,870
3,143 New
3,143 $258,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.6M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.11B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email